Site icon Making the Rounds

Kumar lab uncovers how a protein modification contributes to blood vessel dysfunction

When the endothelia in our blood vessels work well, that thin layer of cells widens the vessels to supply organs with more blood. When endothelia are dysfunctional, it can contribute to cardiovascular diseases, including heart attack and stroke. A new study from the lab of Santosh Kumar, PhD, Assistant Professor in Cardiovascular Medicine, points to one molecular mechanism that may help explain why the lining fails. Their findings are detailed in a recent publication in eLife. 

“Endothelial cells form the innermost lining of blood vessels. Being the first cellular layer of body facing blood, they work as a barrier and actively govern the transfer of blood components to the tissue/organ,” Kumar said. Healthy endothelial cells release nitric oxide, a molecule that tells the vessels to relax.  

Harmful oxygen byproducts, known as reactive oxygen species, work against that process. One way to think of them is as a kind of cellular rust that uses up nitric oxide. One protein known to make these byproducts is p66Shc. Kumar’s lab found that a small tag called SUMO2 can attach to p66Shc at one spot, lysine 81 (K81). Once tagged, p66Shc moves into the mitochondria and makes more of the “rust.”  

To test whether that tag matters, the team engineered mice with a mutation that prevents SUMO2 from modifying p66Shc. After four weeks on a high-fat diet, those mice maintained healthier blood vessel function and showed less oxidative damage than comparison mice, even though cholesterol levels were similar. Mass spectrometry, conducted with collaborators at the University of Massachusetts Chan Medical School and the University of Nebraska Medical Center, confirmed that SUMO2 modifies p66Shc at the identified site. 

So far, the work has demonstrated protection against endothelial dysfunction and oxidative damage in mouse models. Whether the engineered mice are also protected against atherosclerosis or artery plaque buildup remains an open question and is the team’s next area of investigation. “We are further investigating if mice having this mutant protein are protected against atherosclerotic stress. This will help establish p66ShcK81R as a potential therapeutic tool to mitigate vascular diseases,” Kumar said. 

Kumar credited first author Jitendra Kumar, PhD, a former postdoctoral researcher in the lab, and Shravan Uppulapu, PhD, a current postdoctoral researcher, for their contributions to the study. He also acknowledged collaborators at UMass Chan Medical School and the University of Nebraska Medical Center, whose mass spectrometry work was fundamental to identifying the SUMO2 modification. 

Exit mobile version